Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lifestyle1966 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A06594 | 32814993 | Curr Gastroenterol Rep | Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06604 | 32810900 | Liver Int | Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease. | 2020 | Details |
| A06636 | 32799384 | Liver Int | Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06646 | 32795560 | Metabolism | Perturbation of the circadian clock and pathogenesis of NAFLD. | 2020 | Details |
| A06674 | 32785059 | Nutrients | Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral. | 2020 | Details |
| A06678 | 32783310 | Int J Exp Pathol | A "Western Diet" promotes symptoms of hepatic steatosis in spontaneously hypertensive rats. | 2020 | Details |
| A06749 | 32760204 | Int J Biol Sci | Kupffer Cells in Non-alcoholic Fatty Liver Disease: Friend or Foe? | 2020 | Details |
| A06766 | 32755310 | Am J Physiol Gastrointest Liver Physiol | The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2020 | Details |
| A06837 | 32729704 | Minerva Med | Ancient wheats: beneficial effects on insulin resistance. | 2020 | Details |
| A06870 | 32717123 | Aliment Pharmacol Ther | Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention. | 2020 | Details |
| A06875 | 32714888 | Front Public Health | Risk Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population. | 2020 | Details |
| A06879 | 32712103 | Gastroenterology | Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice. | 2020 | Details |
| A06897 | 32706078 | Eur Rev Med Pharmacol Sci | Mediterranean diet and the prevention of non-alcoholic fatty liver disease: results from a case-control study. | 2020 | Details |
| A06916 | 32698306 | Int J Environ Res Public Health | Association of Genetic and Environmental Factors with Non-Alcoholic Fatty Liver Disease in a Chinese Han Population. | 2020 | Details |
| A06949 | 32690164 | Clin Nutr ESPEN | Effect of lifestyle modification education based on health belief model in overweight/obese patients with non-alcoholic fatty liver disease: A parallel randomized controlled clinical trial. | 2020 | Details |
| A06950 | 32690054 | BMC Public Health | Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance? | 2020 | Details |
| A06970 | 32683103 | Clin Gastroenterol Hepatol | Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06977 | 32679195 | Arch Biochem Biophys | (-)-Epicatechin and the comorbidities of obesity. | 2020 | Details |
| A06991 | 32670821 | J Tradit Complement Med | Beneficial effects of Chinese herbs in the treatment of fatty liver diseases. | 2020 | Details |
| A06997 | 32666779 | Pol Arch Intern Med | Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice. | 2020 | Details |
| A06998 | 32666675 | Liver Int | Hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of non-viral risk factors. | 2020 | Details |
| A07040 | 32647367 | Eur J Clin Nutr | The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial. | 2020 | Details |
| A07052 | 32640331 | Food Chem Toxicol | Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease. | 2020 | Details |
| A07062 | 32636281 | BMJ Open | Protocol for a phase IV, open-label feasibility study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background therapy (OBT) plus maraviroc or OBT alone. | 2020 | Details |
| A07066 | 32634622 | Clin Gastroenterol Hepatol | Real-World Burden of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07076 | 32630732 | Antioxidants (Basel) | Serum Malondialdehyde is Associated with Non-Alcoholic Fatty Liver and Related Liver Damage Differentially in Men and Women. | 2020 | Details |
| A07085 | 32628898 | United European Gastroenterol J | Metabolic endoscopy: Today's science-tomorrow's treatment. | 2020 | Details |
| A07104 | 32621584 | Endocr Connect | Fighting liver fat. | 2020 | Details |
| A07111 | 32619031 | Diabet Med | Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes. | 2020 | Details |
| A07132 | 32607889 | Methods Mol Biol | An Obesogenic Dietary Mouse Model of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07141 | 32605253 | Cancers (Basel) | Current and Future Treatments in the Fight Against Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07143 | 32603950 | Atherosclerosis | Impact of lifestyle and cardiovascular risk factors on early atherosclerosis in a large cohort of healthy adolescents: The Early Vascular Ageing (EVA)-Tyrol Study. | 2020 | Details |
| A07211 | 32581074 | mSphere | Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity. | 2020 | Details |
| A07212 | 32580141 | EBioMedicine | Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans. | 2020 | Details |
| A07240 | 32571100 | J Endourol | Nonalcoholic Fatty Liver Disease Is an Independent Risk Factor for Nephrolithiasis in Women: Findings from NHANES III. | 2020 | Details |
| A07243 | 32570776 | Int J Mol Sci | Epidemiology: Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan. | 2020 | Details |
| A07244 | 32569680 | Metabolism | Metabolic liver disease in diabetes - From mechanisms to clinical trials. | 2020 | Details |
| A07270 | 32559194 | PLoS Med | Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts. | 2020 | Details |
| A07281 | 32556752 | Surg Endosc | Long-term effects of one-anastomosis gastric bypass on liver histopathology in NAFLD cases: a prospective study. | 2020 | Details |
| A07285 | 32555123 | Med Sci Monit | Association between Cardiorespiratory Fitness, Relative Grip Strength with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07313 | 32543284 | Expert Opin Pharmacother | Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis. | 2020 | Details |
| A07323 | 32537840 | Hepatol Res | Modelling the economic and clinical burden of non-alcoholic steatohepatitis in East Asia: Data from Hong Kong. | 2020 | Details |
| A07333 | 32533233 | Pathologe | [Histopathological diagnosis and differential diagnosis of nonalcoholic fatty liver disease]. | 2020 | Details |
| A07355 | 32526850 | Molecules | The Potential Therapeutic Value of Medicinal Plants in the Management of Metabolic Disorders. | 2020 | Details |
| A07368 | 32524096 | Hawaii J Health Soc Welf | Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i. | 2020 | Details |
| A07377 | 32521615 | Cancers (Basel) | Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune Response. | 2020 | Details |
| A07383 | 32518675 | Clin Diabetes Endocrinol | Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand? | 2020 | Details |
| A07393 | 32515888 | J Occup Health | Effects of obesity, metabolic syndrome, and non-alcoholic or alcoholic elevated liver enzymes on incidence of diabetes following lifestyle intervention: A subanalysis of the J-DOIT1. | 2020 | Details |
| A07414 | 32509277 | F1000Res | Recent advances in understanding and managing pediatric nonalcoholic fatty liver disease. | 2020 | Details |
| A07461 | 32486073 | Cancers (Basel) | Exercise Attenuates the Transition from Fatty Liver to Steatohepatitis and Reduces Tumor Formation in Mice. | 2020 | Details |
| A07506 | 32467498 | Am J Ther | How to Reduce Cardiovascular Risk in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07520 | 32460375 | J Food Sci | Effects of polar compounds in fried palm oil on liver lipid metabolism in C57 mice. | 2020 | Details |
| A07593 | 32431528 | Diabetes Metab Syndr Obes | Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran: A Population-Based Study. | 2020 | Details |
| A07595 | 32431115 | Diabetes Metab J | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association. | 2020 | Details |
| A07609 | 32424494 | Adv Exp Med Biol | Non-alcoholic Fatty Liver Disease and Diabetes Mellitus. | 2021 | Details |
| A07615 | 32420328 | Biomed Res Int | Prevalence of Metabolic Syndrome and Nonalcoholic Fatty Liver Disease among Premenopausal and Postmenopausal Women in Ho Municipality: A Cross-Sectional Study. | 2020 | Details |
| A07646 | 32410310 | Liver Int | Objectively measured sedentary time, physical activity and liver enzyme elevations in US Hispanics/Latinos. | 2020 | Details |
| A07648 | 32409850 | Internist (Berl) | [New pharmacological treatment options for nonalcoholic fatty liver disease]. | 2020 | Details |
| A07708 | 32382557 | Biomed Res Int | A Candidate Drug for Nonalcoholic Fatty Liver Disease: A Review of Pharmacological Activities of Polygoni Multiflori Radix. | 2020 | Details |
| A07746 | 32366600 | J Pharmacol Exp Ther | Ezetimibe Markedly Reduces Hepatic Triglycerides and Cholesterol in Rats Fed on Fish Oil by Increasing the Expression of Cholesterol Efflux Transporters. | 2020 | Details |
| A07750 | 32365405 | J Gastroenterol Hepatol | Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non-alcoholic steatohepatitis. | 2020 | Details |
| A07789 | 32354182 | J Clin Med | Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research. | 2020 | Details |
| A07792 | 32353483 | J Hepatol | Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum. | 2020 | Details |
| A07801 | 32351917 | Front Pediatr | Nonalcoholic Fatty Liver Disease Is Associated With Low Skeletal Muscle Mass in Overweight/Obese Youths. | 2020 | Details |
| A07810 | 32349708 | BMC Gastroenterol | High incidence of hepatocellular carcinoma and cirrhotic complications in patients with psychiatric illness: a territory-wide cohort study. | 2020 | Details |
| A07812 | 32349377 | Int J Mol Sci | Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients. | 2020 | Details |
| A07845 | 32337056 | BMJ Open Gastroenterol | Changes in metabolic complications in patients with alcoholic fatty liver disease monitored over two decades: NAGALA study. | 2020 | Details |
| A07869 | 32329453 | JNMA J Nepal Med Assoc | Burden of Alcoholic Liver Disease in a Tertiary Care Center: A Descriptive Cross-sectional Study. | 2020 | Details |
| A07886 | 32323115 | Eur J Epidemiol | Adherence to a plant-based, high-fibre dietary pattern is related to regression of non-alcoholic fatty liver disease in an elderly population. | 2020 | Details |
| A07896 | 32318489 | J Family Med Prim Care | Determination of association between nonalcoholic fatty liver disease and carotid artery atherosclerosis among nondiabetic individuals. | 2020 | Details |
| A07913 | 32312927 | Pol Przegl Chir | Prevalence of non-alcoholic fatty liver disease and hypercholesterolemia in patients with gallstone disease undergoing laparoscopic cholecystectomy. | 2019 | Details |
| A07919 | 32309672 | Contemp Clin Trials Commun | Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH. | 2020 | Details |
| A07925 | 32306666 | Zhonghua Gan Zang Bing Za Zhi | [Circadian clock and non-alcoholic fatty liver disease]. | 2020 | Details |
| A07928 | 32306654 | Zhonghua Gan Zang Bing Za Zhi | [Diagnosis and treatment strategies for fatty liver when obesity coexists with alcohol consumption]. | 2020 | Details |
| A07930 | 32306652 | Zhonghua Gan Zang Bing Za Zhi | [Diagnosis and therapeutic strategies for non-obese type of non-alcoholic fatty liver diseases]. | 2020 | Details |
| A07943 | 32303170 | Curr Pharm Des | Hepatoprotective Effects of Resveratrol in Non-Alcoholic Fatty Live Disease. | 2021 | Details |
| A07972 | 32293287 | BMC Gastroenterol | Combined effects of lifestyle risk factors on fatty liver index. | 2020 | Details |
| A07991 | 32286882 | Am J Physiol Endocrinol Metab | HDL-apoA-I kinetics in response to 16 wk of exercise training in men with nonalcoholic fatty liver disease. | 2020 | Details |
| A08005 | 32281943 | JMIR Mhealth Uhealth | Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial. | 2020 | Details |
| A08021 | 32279091 | Mamm Genome | Epigenetic contribution to obesity. | 2020 | Details |
| A08033 | 32274915 | Minerva Pediatr | Metabolic syndrome in children. | 2020 | Details |
| A08053 | 32267638 | Ned Tijdschr Geneeskd | [Non-alcoholic fatty liver disease; a full-bodied epidemic]. | 2020 | Details |
| A08061 | 32264657 | Korean J Intern Med | Association between high fatty liver index and development of colorectal cancer: a nationwide cohort study with 21,592,374 Korean. | 2020 | Details |
| A08071 | 32258520 | Transl Gastroenterol Hepatol | Epidemiology of non-alcoholic and alcoholic fatty liver diseases. | 2020 | Details |
| A08115 | 32241197 | Expert Rev Gastroenterol Hepatol | Obeticholic acid for the treatment of nonalcoholic steatohepatitis. | 2020 | Details |
| A08160 | 34908794 | Ayu | Efficacy of Sharapunkhadi powder (a polyherbal formulation) and lifestyle modification in the management of nonalcoholic fatty liver disease-A randomized placebo-controlled clinical trial. | 2021 | Details |
| A08175 | 32218121 | Nutrients | Negative Energy Balance Induced by Exercise or Diet: Effects on Visceral Adipose Tissue and Liver Fat. | 2020 | Details |
| A08194 | 32211252 | Cureus | Anthropometric Measurements and Lifestyle Characteristics of Individuals with Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A08200 | 32207804 | JAMA | Nonalcoholic Steatohepatitis: A Review. | 2020 | Details |
| A08221 | 32195455 | JHEP Rep | Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease. | 2020 | Details |
| A08244 | 32189929 | J Clin Exp Hepatol | Role of Magnetic Resonance Imaging in the Monitoring of Patients with Nonalcoholic Fatty Liver Disease: Comparison with Ultrasonography, Lipid Profile, and Body Mass Index. | 2019 | Details |
| A08254 | 32187014 | J Pediatr Endocrinol Metab | Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review. | 2020 | Details |
| A08277 | 32171275 | BMC Pediatr | Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017. | 2020 | Details |
| A08286 | 32169417 | Biochem Pharmacol | Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD). | 2020 | Details |
| A08297 | 32164541 | BMC Gastroenterol | Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. | 2020 | Details |
| A08299 | 32161549 | Front Pharmacol | Relationship Between Ginsenoside Rg3 and Metabolic Syndrome. | 2020 | Details |
| A08327 | 32151660 | Metabolism | Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis. | 2020 | Details |
| A08347 | 32146704 | Adv Ther | Managing NAFLD in Type 2 Diabetes: The Effect of Lifestyle Interventions, a Narrative Review. | 2020 | Details |
| A08357 | 32145139 | BJOG | Overweight and obesity status from the prenatal period to adolescence and its association with non-alcoholic fatty liver disease in young adults: cohort study. | 2020 | Details |
| A08390 | 32128995 | Pediatr Obes | Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: A pilot, randomized trial. | 2020 | Details |